# Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

> **NCT04578873** · PHASE1 · COMPLETED · sponsor: **Qpex Biopharma, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DRUG:** QPX7831
- **DRUG:** placebo comparator

## Key facts

- **NCT ID:** NCT04578873
- **Lead sponsor:** Qpex Biopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-13
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04578873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04578873, "Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT04578873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*